1.04
Precedente Chiudi:
$1.055
Aprire:
$1.05
Volume 24 ore:
814.70K
Relative Volume:
0.65
Capitalizzazione di mercato:
$142.72M
Reddito:
$4.35M
Utile/perdita netta:
$-45.53M
Rapporto P/E:
-0.963
EPS:
-1.08
Flusso di cassa netto:
$-44.79M
1 W Prestazione:
-2.80%
1M Prestazione:
-5.45%
6M Prestazione:
-30.67%
1 anno Prestazione:
+34.52%
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Nome
Lucid Diagnostics Inc
Settore
Industria
Telefono
212 949 4319
Indirizzo
360 MADISON AVENUE, NEW YORK
Confronta LUCD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LUCD
Lucid Diagnostics Inc
|
1.04 | 107.50M | 4.35M | -45.53M | -44.79M | -1.08 |
![]()
ABT
Abbott Laboratories
|
133.89 | 236.51B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
98.06 | 144.75B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
371.22 | 142.80B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
95.74 | 121.80B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
74.66 | 43.78B | 5.69B | 1.41B | 577.90M | 6.95 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-12-27 | Iniziato | Ascendiant Capital Markets | Buy |
2021-11-08 | Iniziato | BTIG Research | Buy |
2021-11-08 | Iniziato | Cantor Fitzgerald | Overweight |
2021-11-08 | Iniziato | Needham | Buy |
Lucid Diagnostics Inc Borsa (LUCD) Ultime notizie
Lucid Diagnostics (NASDAQ:LUCD) Cut to "Sell" at Wall Street Zen - MarketBeat
Lucid reports encouraging results from EsoGuard study - MSN
Lucid Diagnostics Completes Public Offering for $26.9 Million - MSN
Tech Rally: What is Lucid Diagnostics Inc. s 5 year growth outlookBreakout Watch & Advanced Technical Signal Analysis - khodrobank.com
Breakouts Watch: What is Lucid Diagnostics Incs valuation compared to sectorTake Profit & Stepwise Trade Signal Implementation - khodrobank.com
Retail Trends: Whats the MACD signal for Lucid Diagnostics Inc2025 Fundamental Recap & Real-Time Volume Triggers - خودرو بانک
Downgrade Watch: Is Lucid Diagnostics Inc. likely to announce a buybackJuly 2025 Update & Consistent Profit Trading Strategies - خودرو بانک
Is Qiagen NV stock a smart retirement pick2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - khodrobank.com
Lucid Diagnostics dips after pricing $25M stock offering - MSN
Trend Review: Is Lucid Diagnostics Inc gaining market share2025 Sector Review & Momentum Based Trading Ideas - خودرو بانک
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
Block Trades: What is the long term forecast for Lucid Diagnostics Inc stock2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Will Lucid Diagnostics Inc outperform tech stocksWeekly Trade Recap & Proven Capital Preservation Methods - khodrobank.com
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs - citybiz
Aug Wrap: What dividend growth rate does Lucid Diagnostics Inc offer2025 Support & Resistance & Detailed Earnings Play Strategies - خودرو بانک
Growth Value: Is Lucid Diagnostics Inc. exposed to currency risksJuly 2025 Volume & Verified Chart Pattern Trade Signals - خودرو بانک
Lucid Diagnostics Inc. Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs - MarketScreener
Price Action: Whats the MACD signal for Lucid Diagnostics IncMarket Performance Recap & Expert Curated Trade Ideas - خودرو بانک
US Market Wrap: How much upside does Lucid Diagnostics Inc. haveBuy Signal & Low Drawdown Investment Ideas - خودرو بانک
Market Overview: Will Lucid Diagnostics Inc. outperform during market ralliesCPI Data & Daily Volume Surge Signals - خودرو بانک
Aug PostEarnings: Should I buy Lucid Diagnostics Inc stock nowStop Loss & Advanced Technical Signal Analysis - خودرو بانک
Midtown medical testing company raises $27M with the prospect of Medicare coverage - Crain's New York Business
Lucid Diagnostics, New York, closes public offering of common stock - Medical Buyer
Duke University to License Endoscopic Esophageal Imaging Tech to PAVmed - Medical Product Outsourcing
Alyeska Investment Group L.P. Makes New $2.81 Million Investment in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics announces proposed public offering of common stock - MSN
Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
PAVmed’s Lucid Diagnostics Completes Public Stock Offering - TipRanks
Lucid Diagnostics Announces Public Stock Offering - MSN
Lucid Diagnostics announces closing of public offering of common stock - MarketScreener
Lucid Diagnostics Closes Roughly $26.9 Million Stock Offering - MarketScreener
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - StreetInsider
Lucid Diagnostics prices $25 million public offering of common stock - Investing.com India
Lucid Diagnostics stock maintains Buy rating at BTIG after $25M raise - Investing.com Canada
Lucid Diagnostics Prices $25 Mln Public Offering At $1.00 Per Share - Nasdaq
Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering - 富途牛牛
Lucid Diagnostics stock maintains Buy rating at BTIG after $25M raise By Investing.com - Investing.com South Africa
Lucid Prices Public Share Offering - Baystreet.ca
Lucid Diagnostics Prices $25 Million Public Offering - MarketScreener
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PR Newswire
Lucid Diagnostics prices $25 million public offering of common stock By Investing.com - Investing.com UK
Lucid Diagnostics Announces Pricing of Public Offering to Fund Cancer Prevention Initiatives - geneonline.com
Lucid Diagnostics announces pricing of public offering of common stock - MarketScreener
Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock - Barchart.com
Lucid Diagnostics Inc Azioni (LUCD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):